Urinary nucleosides as biological markers for patients with colorectal cancer

World Journal of Gastroenterology

Volumn 11, Issue 25, 2005, Pages 3871-3876

  Zheng, Yu Fang ^a   Yang, Jun ^a   Zhao, Xin Jie ^a   Feng, Bo ^b   Kong, Hong Wei ^a   Chen, Ying Jie ^c   Lv, Shen ^a,c   Zheng, Min Hua ^b   Xu, Guo Wang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Biological markers; Colorectal cancer; High performance liquid chromatography; Nucleosides

Indexed keywords

1 METHYLADENOSINE; 6 N METHYLADENOSINE; ADENOSINE; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CYTIDINE; GUANOSINE; INOSINE; NUCLEOSIDE; PSEUDOURIDINE; TRANSFER RNA; URIDINE;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; COLON ADENOMA; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; INTESTINE VILLUS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT MONITORING; PRINCIPAL COMPONENT ANALYSIS; RECTUM ADENOMA; RNA DEGRADATION; TUMOR VOLUME; URINALYSIS;

EID: 22644434361     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i25.3871     Document Type: Article

References (23)

1. Xu G, Di Stefano C, Liebich HM, Zhang Y, Lu P. Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients. J Chromatogr B 1999; 732: 307-313
2. Liebich HM, Xu G, Di Stefano C, Lehmann R. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients. J Chromatogr A 1998; 793: 341-347
3. Xu G, Lu X, Zhang Y, Lu P, Di Stefano C, Lehmann R, Liebich HM. Two approaches to determining the urinary excretion patterns of nucleosides- HPLC and CE. Se Pu 1999; 17: 97-101
4. Zhao R, Xu G, Yue B, Liebich HM, Zhang Y. Artificial neural network classification based on capillary electrophoresis of urinary nucleosides for the clinical diagnosis of tumors. J Chromatogr A 1998; 828: 489-496
5. Xu G, Liebich HM, Lehmann R, Muller-Hagedorn S. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients. Methods Mol Biol 2001; 162: 459-474
6. Xu G, Schmid HR, Lu X, Liebich HM, Lu P. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method. Biomed Chromatogr 2000; 14: 459-463
7. Zheng YF, Xu GW, Liu DY, Xiong JH, Zhang PD, Zhang C, Yang Q, Lv S. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography. Electrophoresis 2002; 23: 4104-4109
8. Borek E, Kerr SJ. A typical transfer RNA's and their origin in neoplastic cells. Adv Cancer Res 1972; 15: 163-190
9. Borek E, Baliga BS, Gehrke CW, Kuo CW, Belman S, Troll W, Waalkes TP. High turnover rate of transfer RNA in tumor tissue. Cancer Res 1977; 37: 3362-3366
10. Mandel LR, Srinivasan PR, Borek E. Origin of urinary methylated purines. Nature 1966; 209: 586-588
11. Sander G, Topp, H, Heller-Schoch G, Wieland J, Schoch G. Ribonucleic add turnover in man: RNA catabolites in urine as measure for the metabolism of each of the three major species of RNA. Clin Sci 1986; 71: 367-374
12. Liebich HM, Di Stefano C, Wixforth A, Schmid HR. Quantitation of urinary nucleosides by high-performance liquid chromatography. J Chromatogr A 1997; 763: 193-197
13. Zheng YF, Chen YJ, Pang T, Shi XZ, Kong HW, Lu S, Yang Q, Xu GW. Investigation of urinary nucleosides excretion of intestinal cancer patients by reversed-phase high performance liquid chromatography. Se Pu 2002; 20: 498-501
14. Gehrke CW, Kuo KC, Waalkes TP, Borek E. Patterns of urinary excretion of modified nucleosides. Cancer Res 197; 39: 1150-1153
15. Liebich HM, Xu G, Di Stefanoc C, Lehmann R, Haring HU, Lu P, Zhang Y. Analysis of normal and modified nucleosides in Urine by Capillary Electrophoresis. Chromatographia 1997; 45: 396-401
16. Zheng YF, Zhang Y, Liu DY, Guo XL, Mei SR, Xiong JH, Kong HW, Zhang C, Xu G. Analysis of Urinary Nucleosides by Micellar Electrokinetic Chromatography. Chemical J Chinese Universities 2001; 22: 912-915
17. Kim KR, La S, Kim A, Kim JH, Liebich HM. Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from uterine myoma and cervical cancer patients. J Chromatogr B 2001; 754: 97-106
18. La S, Cho JH, Kim JH, Kim KR. Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleoside from throid cancer patients. Anal Chim Acta 2003; 486: 171-182
19. Borek E, Sharma OK, Buschman FL, Cohn DL, Penley KA, Judson FN, Dobozin BS, Horsburgh CR Jr, Kirkpatrick CH. Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome. Cancer Res 1986; 46: 2557-2561
20. Fischbein A, Sharma OK, Selikoff IJ, Borek E. Urinary excretion of modified nucleosides in patients with malignant mesothelioma. Cancer Res 1983; 43: 2971-2974
21. Rasmuson T, Bjork GR. Urinary excretion of pseudouridine and prognosis of patients with malignant lymphoma. Acta Oncol 1995; 34: 61-67
22. Waalkes TP, Abeloff MD, Ettinger DS, Woo KB, Gehrke CW, Kuo KC, Borek E. Biological markers and small cell carcinoma of the lung: a clinical evaluation of urinary ribonucleosides. Cancer 1982; 50: 2457-2464
23. Sander G, Hulsemann J, Topp H, Heller-Schoch G, Schoch G. Protein and RNA turnover in preterm infants and adults: a comparison based on urinary excretion of 3-methylhistidine and of modified one-way RNA catabolites. Ann Nutr Metab 1986; 30: 137-142